chr11-2972169-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_005969.4(NAP1L4):āc.248A>Gā(p.Lys83Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000104 in 1,609,044 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 33)
Exomes š: 0.00010 ( 1 hom. )
Consequence
NAP1L4
NM_005969.4 missense
NM_005969.4 missense
Scores
2
7
9
Clinical Significance
Conservation
PhyloP100: 5.88
Genes affected
NAP1L4 (HGNC:7640): (nucleosome assembly protein 1 like 4) This gene encodes a member of the nucleosome assembly protein (NAP) family which can interact with both core and linker histones. It can shuttle between the cytoplasm and nucleus, suggesting a role as a histone chaperone. This gene is one of several located near the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.4128213).
BS2
High AC in GnomAd4 at 22 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAP1L4 | NM_005969.4 | c.248A>G | p.Lys83Arg | missense_variant | 5/16 | ENST00000380542.9 | NP_005960.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAP1L4 | ENST00000380542.9 | c.248A>G | p.Lys83Arg | missense_variant | 5/16 | 1 | NM_005969.4 | ENSP00000369915.4 |
Frequencies
GnomAD3 genomes AF: 0.000144 AC: 22AN: 152250Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
22
AN:
152250
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000532 AC: 13AN: 244478Hom.: 0 AF XY: 0.0000677 AC XY: 9AN XY: 132898
GnomAD3 exomes
AF:
AC:
13
AN:
244478
Hom.:
AF XY:
AC XY:
9
AN XY:
132898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000100 AC: 146AN: 1456794Hom.: 1 Cov.: 31 AF XY: 0.000119 AC XY: 86AN XY: 724802
GnomAD4 exome
AF:
AC:
146
AN:
1456794
Hom.:
Cov.:
31
AF XY:
AC XY:
86
AN XY:
724802
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000144 AC: 22AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74388
GnomAD4 genome
AF:
AC:
22
AN:
152250
Hom.:
Cov.:
33
AF XY:
AC XY:
16
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 19, 2024 | The c.248A>G (p.K83R) alteration is located in exon 5 (coding exon 4) of the NAP1L4 gene. This alteration results from a A to G substitution at nucleotide position 248, causing the lysine (K) at amino acid position 83 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;T;T;T;T;T;T;T;.;.
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;.;.;.;.;.;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;N;N;D;D;D;D;D;D;D;D;D
REVEL
Benign
Sift
Uncertain
.;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
D;D;D;.;D;D;.;.;.;.;D;.
Polyphen
1.0
.;D;.;.;.;.;.;.;.;.;.;.
Vest4
MVP
MPC
0.75
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at